Origin Agritech Q4 2025 Earnings Report

Origin Agritech EPS Results

• Actual EPS: -$0.26
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Origin Agritech Revenue Results

• Actual Revenue: $1.43 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Origin Agritech Announcement Details

• Quarter: Q4 2025
• Date: 1/30/2026
• Time: Before Market Opens
• Conference Call Date: Monday, February 2, 2026
• Conference Call Time: 8:00AM ET

Origin Agritech (NASDAQ:SEED) (NASDAQ:SEED) is an agricultural biotechnology company focused on the research, development, production and sale of hybrid rice seeds. The company’s core business activities center on the application of molecular marker‐assisted selection and genomics to develop high‐yielding, disease‐resistant and stress‐tolerant rice varieties. Its product portfolio includes proprietary cytoplasmic male sterile (CMS) lines, hybrid parent lines and commercial seed varieties tailored to the agronomic needs of rice growers.

Origin Agritech primarily serves the major rice‐producing provinces of China, where it has established breeding stations, seed production bases and a distribution network to supply certified hybrid seeds. Over time, the company has explored partnerships and export opportunities in Southeast Asia, Africa and other emerging markets, leveraging its breeding platforms to address regional climate and soil challenges. These collaborative efforts aim to adapt core genetic traits to local growing conditions and to support global food security initiatives.

Founded with the mission of improving crop productivity through seed innovation, Origin Agritech has built a portfolio of patents covering molecular markers, breeding methodologies and key genetic traits. The company actively collaborates with academic institutions, government research bodies and seed producers to accelerate product development and commercialization. Its leadership team brings together expertise in plant genetics, agronomy and commercial operations to guide strategic growth and technological advancement.

Origin Agritech Q4 2025 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: The company reports a full operational recovery with leadership in place and headcount rising from 68 to 97, positioning Origin Agritech to resume growth initiatives.
• Positive Sentiment: R&D and production infrastructure were upgraded — Beijing and Sanya stations refreshed, a new Zhengzhou station opened, and Guiyang is expected to come online in Q1 2026, while the germplasm pipeline has been largely renewed.
• Positive Sentiment: Origin accelerated commercialization of GMO and functional gene‑editing technologies through a strategic alliance with China Golden Marker, which could be a material long‑term revenue driver.
• Negative Sentiment: Fiscal 2025 revenue fell to CNY 91.3 million (a 90% decline YoY) and net loss was CNY 53.3 million, driven by reduced non‑proprietary seed sales during Xinjiang facility upgrades and increased competition for legacy products.
• Positive Sentiment: Liquidity strengthened as cash and equivalents rose 89% to CNY 15.9 million after a $5.38 million equity raise, with proceeds allocated to working capital, market expansion, and facility upgrades.

Presentation

[Operator]

Thank you for standing by and welcome to the Origin Agritech fiscal year 2025 results conference call. Please note that today's call is being recorded. It is now my pleasure to introduce Matthew Abenante of Strategic Investor Relations.

[Matthew Abenante, President and Founder at Strategic Investor Relations]

Thank you, Operator, and thanks to all of you for joining us today on the Origin Agritech Business Update conference call. Joining us on the call today are Mr. Weibin Yan, Chief Executive Officer, and Mr. Patrick Cheng, Chief Financial Officer. Before we begin, I would like to remind our listeners that any statements on this call that are not historical facts are forward-looking statements. Today's call includes forward-looking statements that address expected future business and financial performance and financial conditions and contain words like expect, anticipate, intend, plan, believe, seek, will, would, target, and similar expressions and variations. Forward-looking statements address matters that are uncertain. Forward-looking statements are not guarantees of future performance and are based on assumptions and expectations which may not be realized.

[Matthew Abenante, President and Founder at Strategic Investor Relations]

They're based on management's current expectations, assumptions, estimates, and projections about the company and the industry, but involve a number of risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause the company's actual results to differ materially from those discussed in forward-looking statements are failure to develop and market new products and optimally manage product life cycles, ability to respond to market acceptance, rules, regulations, and policies affecting our products, failure to appropriately manage process safety and product stewardship issues, changes in laws and regulations or political conditions, global economic and capital markets conditions such as inflation, interest, and currency exchange rates, business or supply disruptions, natural disasters and weather events and patterns, ability to protect and enforce the company's intellectual property rights, and separation of underperforming or non-strategic assets or businesses.

[Matthew Abenante, President and Founder at Strategic Investor Relations]

The company undertakes no duty or obligation to publicly revise or update any forward-looking statements as a result of future developments or new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Although the company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You're urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements which are qualified in their entirety by these cautionary statements. With that, I would like to turn the call over to our first speaker, Mr. Weibin Yan, Chief Executive Officer of Origin Agritech. Hello, Mr. Yan.

[Weibin Yan, CEO at Origin Agritech]

Thank you, Matthew, and thank you all for joining us today. I'm delighted to speak with you about what has been transformative year for Origin Agritech. It has been the first year for me to take the CEO role in the company from September 2024 to September 2025. If I had to capture the theme of this year in a single word, it won't be recovery. We have achieved a full recovery of our team, our research capabilities, our seed production, and processing facilities, and our sales network infrastructure. Origin Agritech is now ready for a new march forward onto our new leadership. In November 2024, we announced our three-stage strategic plan that the company is fully committed to executing. Stage one is recovery, spanning calendar year 2025 and 2026. Stage two is to stand up, covering 2027 through 2029.

[Weibin Yan, CEO at Origin Agritech]

Stage three is our return to an industry-leading position, which we aim to achieve from 2030 through 2032. We are confident in this roadmap and already seeing strong progress in stage one. Let me share our key accomplishments in 2025. Our senior leadership team is now fully in place and energized. We have recovered our headcount from 68 to 97 professionals, a testament to our renewed ability to attract and retain top talents. We are also reshaping our decentralization efforts across the organization to drive efficiency and innovation. On the research front, we have made tremendous strides. We upgraded our Beijing Station and the Sanya Station and opened a new station in Zhengzhou, Henan Province. Zhengzhou is in Henan Province. Our research facility in Guiyang, that's Guizhou Province, is under construction and will be opened in Q1 2026.

[Weibin Yan, CEO at Origin Agritech]

We have mostly renewed our product portfolio, and our research pipeline is now stocked with the most competitive germplasm targeting the next generation of industry competition. The commercialization of GMO and functional gene editing technology has been accelerated through a strategic alliance with China Golden Marker. Our upgraded Xinjiang production and processing facility is now back to industry-leading standards. On the sales front, our team and the infrastructure have been greatly improved. We established a new sales force in the Northeast China, East China provinces, and our sales team and entity restructuring have been mostly concluded in December 2025. Additionally, Beijing Origin achieved its seed production operation license in December 2025, making another important milestone.

[Weibin Yan, CEO at Origin Agritech]

We are confident that the strategic decisions and investments we made in 2025 have positioned Origin Agritech for sustainable long-term growth and will deliver significant value to the farmers and our shareholders in the coming years ahead. Thank you, and I will turn the call over to our CFO, Patrick Cheng, to discuss our financial results. Thank you, Matthew.

[Patrick Cheng, CFO at Origin Agritech]

Thank you, Mr. Yan. I will review our financial performance for the fiscal year 2025. For fiscal year 2025, we reported total revenues of CNY 91.3 million or $12.9 million. This represents a 90% decrease from the previous year. This decline was primarily driven by two factors. First, a decrease in sales of non-proprietary seed varieties as we strategically shifted focus and temporarily reduced some external production services during the upgrade of our Xinjiang facility. Second, increased market competition for our legacy proprietary seed products. This resulted in a net loss attributable to Origin of CNY 53.3 million or $7.5 million. It's important to note that our fiscal year 2024 results included a one-time gain from a subsidiary disposal, which was not repeated this year. Turning to our balance sheet and cash flow, we ended the year in a strong liquidity position.

[Patrick Cheng, CFO at Origin Agritech]

Our cash and cash equivalents increased by 89% to CNY 15.9 million. During the year, we successfully raised $5.38 million through the sale of ordinary shares. These funds are being strategically deposited for working capital, market expansion, and facility upgrades. Net cash used in operating activities was CNY 22.9 million, reflecting our investment in inventory and operations. Net cash used in investing activities was CNY 13.7 million, primarily for the upgrades to our production facilities. Net cash provided by financing activities was CNY 44.3 million, largely from the capital raise. In summary, while our 2025 financial results reflect a period of transition and strategic investment, we have strengthened our balance sheet and allocated capital to the key drivers of future growth. We are confident that this investment in technology, infrastructure, and people will create significant value for our shareholders in the coming years. Thank you.

[Operator]

Thank you. This does conclude today's program, and we appreciate your participation. You may now disconnect.

Participants

Executives

• Patrick Cheng, CFO
• Weibin Yan, CEO

Analysts

• Matthew Abenante, President and Founder at Strategic Investor Relations